Abstract 570: Preclinical insights into 161Tb-trastuzumab and immune checkpoint combination therapy for cancer in a HER2-expressing murine cancer modelSigrid Cold, Lotte K. Kristensen, Andreas Kjær et al.|Cancer Research|2025Cited by 0
In Vivo Studies of [ <sup>161</sup> Tb]Tb-Trastuzumab Radiopharmaceutical Therapy in Human Epidermal Growth Factor Receptor 2–Expressing Breast Tumors Show High Tumor Uptake and Tumor Growth SuppressionSigrid Cold, Lotte K. Kristensen, Carsten H. Nielsen et al.|Journal of Nuclear Medicine|2026Cited by 0